3

Takeda Pharmaceutical Company · 2017. 12. 19. · IIN014635/02-140308 r IdliePWBCTBHTeJ1bHOCTb K npenaparry AK TOBEFI/IH© aHaJIOrH¼Hb1M npenaparraM, AeK01MrreHcup0BaHHa51 cepÅeHHa51

Download PDF Report

Upload
others
View
0
Download
0

Embed Size (px)

Citation preview

Page 1: Takeda Pharmaceutical Company · 2017. 12. 19. · IIN014635/02-140308 r IdliePWBCTBHTeJ1bHOCTb K npenaparry AK TOBEFI/IH© aHaJIOrH¼Hb1M npenaparraM, AeK01MrreHcup0BaHHa51 cepÅeHHa51

Page 2: Takeda Pharmaceutical Company · 2017. 12. 19. · IIN014635/02-140308 r IdliePWBCTBHTeJ1bHOCTb K npenaparry AK TOBEFI/IH© aHaJIOrH¼Hb1M npenaparraM, AeK01MrreHcup0BaHHa51 cepÅeHHa51

Page 3: Takeda Pharmaceutical Company · 2017. 12. 19. · IIN014635/02-140308 r IdliePWBCTBHTeJ1bHOCTb K npenaparry AK TOBEFI/IH© aHaJIOrH¼Hb1M npenaparraM, AeK01MrreHcup0BaHHa51 cepÅeHHa51

Takeda Battleboard (1)

Takeda Battleboard (1)

Documents

Takeda Pharmaceutical Company Limited · 2019-06-28 · As used in this annual report, references to the “Company,” “Takeda,” “we,” “us” and “our” are to Takeda

Takeda Pharmaceutical Company Limited · 2019-06-28 · As used in this annual report, references to the “Company,” “Takeda,” “we,” “us” and “our” are to Takeda

Documents

Takeda Research nvestment, nc. - Stanford Universityweb.stanford.edu/group/us-atmc/cgi-bin/us-atmc/wp... · 2009-10-29 · Takeda Research Investment, Inc. Takeda Research Investment,

Takeda Research nvestment, nc. - Stanford Universityweb.stanford.edu/group/us-atmc/cgi-bin/us-atmc/wp... · 2009-10-29 · Takeda Research Investment, Inc. Takeda Research Investment,

Documents

Takeda newsletter1 Summer 140716

Takeda newsletter1 Summer 140716

Documents

ACCESS TO MEDICINES - Takeda

ACCESS TO MEDICINES - Takeda

Documents

Marketing

Annual Report 2014 - Takeda · Takeda Annual Report 2014 1 Relationship between CSR and Sustainability at Takeda 1781 This report offers an integrated explanation of Takeda’s strategies

Annual Report 2014 - Takeda · Takeda Annual Report 2014 1 Relationship between CSR and Sustainability at Takeda 1781 This report offers an integrated explanation of Takeda’s strategies

Documents

Takeda Rc Simulated Earthquakes

Takeda Rc Simulated Earthquakes

Documents

Takeda-CiRA Joint Program for iPS Cell ApplicationsCiRA × Takeda = ∞ T-CiRA is a joint research program conducted by Takeda Pharmaceutical Company and Kyoto University’s Center

Takeda-CiRA Joint Program for iPS Cell ApplicationsCiRA × Takeda = ∞ T-CiRA is a joint research program conducted by Takeda Pharmaceutical Company and Kyoto University’s Center

Documents

Prof.Yukio Takeda

Prof.Yukio Takeda

Documents

AK CRANE RANGE - hsmarine.net€¦ · AK . CRANE RANGE. 2. 3 AK . CRANE RANGE AK 7. AK 13 AK 20. AK 30 AK 34. AK 25 AK 10. AK 16. AK. SERIES. Fully foldable knuckle and telescopic

AK CRANE RANGE - hsmarine.net€¦ · AK . CRANE RANGE. 2. 3 AK . CRANE RANGE AK 7. AK 13 AK 20. AK 30 AK 34. AK 25 AK 10. AK 16. AK. SERIES. Fully foldable knuckle and telescopic

Documents

Public Assessment Report - GOV.UK · Alvesco Takeda 80 Inhaler . Alvesco Takeda 160 Inhaler (ciclesonide) This is a summary of the Public Assessment Report (PAR) for Alvesco Takeda

Public Assessment Report - GOV.UK · Alvesco Takeda 80 Inhaler . Alvesco Takeda 160 Inhaler (ciclesonide) This is a summary of the Public Assessment Report (PAR) for Alvesco Takeda

Documents

Documents

Takeda Pharmaceutical Company - SUMMARY OF FINANCIAL … · 2017. 5. 10. · (Note3) Teva Takeda Yakuhin Ltd. is a wholly owned subsidiary of Teva Takeda Pharma Ltd. which is 49%

Takeda Pharmaceutical Company - SUMMARY OF FINANCIAL … · 2017. 5. 10. · (Note3) Teva Takeda Yakuhin Ltd. is a wholly owned subsidiary of Teva Takeda Pharma Ltd. which is 49%

Documents

Takeda-CiRA Joint Program for iPS Cell ApplicationsCiRA × Takeda = Combined strengths, high expectations T-CiRA is a joint research program conducted by Takeda Pharmaceutical Company

Takeda-CiRA Joint Program for iPS Cell ApplicationsCiRA × Takeda = Combined strengths, high expectations T-CiRA is a joint research program conducted by Takeda Pharmaceutical Company

Documents

株式会社シュナイダー・ジャパン THE SCHNEIDER CORP ...schneider.co.jp/download/pdf/aerosmith.pdfAK 825 AK 830 AK 835 AK 840 AK 845 AK 850 AK 855 AK 860 AK 865 AK 870

株式会社シュナイダー・ジャパン THE SCHNEIDER CORP ...schneider.co.jp/download/pdf/aerosmith.pdfAK 825 AK 830 AK 835 AK 840 AK 845 AK 850 AK 855 AK 860 AK 865 AK 870

Documents

Takeda-CiRA Joint Program for iPS Cell Applications · CiRA × Takeda = ∞ T-CiRA is a joint research program conducted by Takeda Pharmaceutical Company and Kyoto University’s

Takeda-CiRA Joint Program for iPS Cell Applications · CiRA × Takeda = ∞ T-CiRA is a joint research program conducted by Takeda Pharmaceutical Company and Kyoto University’s

Documents

Takeda Assistance Form

Takeda Assistance Form

Documents

Documents

Documents

Education

Annual Responsibility Review 2015 - Takeda

Annual Responsibility Review 2015 - Takeda

Documents

TAKEDA NEUROSCIENCE

TAKEDA NEUROSCIENCE

Documents

Takeda Pharmaceuticals v. Amneal Pharmaceuticals

Takeda Pharmaceuticals v. Amneal Pharmaceuticals

Documents

Alvesco Market Definitions Combi R3F1 Alvesco Market R3 Takeda Takeda Takeda Market Segment 3 Segment 2 Segment Mono R3D1 Other All Products from R3 excluding

Alvesco Market Definitions Combi R3F1 Alvesco Market R3 Takeda Takeda Takeda Market Segment 3 Segment 2 Segment Mono R3D1 Other All Products from R3 excluding

Documents

Takeda digital case

Takeda digital case

Business

2016 - Takeda Pharmaceutical Company

2016 - Takeda Pharmaceutical Company

Documents

GAMMAGARD LIQUID - Takeda

GAMMAGARD LIQUID - Takeda

Documents

Takeda Oncology · Takeda Oncology Christophe Bianchi, M.D. President, Global Oncology Business Unit, Takeda Important Notice Forward-Looking Statements This presentation contains

Takeda Oncology · Takeda Oncology Christophe Bianchi, M.D. President, Global Oncology Business Unit, Takeda Important Notice Forward-Looking Statements This presentation contains

Documents

TAKEDA VACCINES

TAKEDA VACCINES

Documents